Analysis of the respiratory syncytial virus (RSV) mRNAs by cDNA cloning, sequencing and related techniques has identified ten different mRNAs, and to date a single encoded polypeptide has been identified for each. We are interested in (i) continuing the analysis of the viral mRNAs and their translational open reading frames (ORFs) to detect possible additional mRNAs and polypeptides and to learn more about the details of RSV gene expression, (ii defining the extent of sequence diversity among RSV isolates, and (iii) analyzing the individual RSV proteins to determine their intracellular and virion locations and their functions. We have continued the analysis of the 1A protein (whose name has been changed to SH [small hydrophobic] to be consistent with the nomenclature for simian virus 5 and mumps virus). The SH protein was shown to be an integral membrane protein that is processed by a complex intracellular pathway that results in two nonglycosylated and two glycosylated species. The processing pathway and structural differences between the different forms have been shown to be conserved between the two RSV antigenic subgroups. Experiments are continuing to determine the membrane orientation, site of glycosylation, and the oligomeric status of the different forms of the SH protein. In other work, a complete nucleotide sequence was determined for the 22K gene of strain 18537. Comparison with the previously-determined strain A2 sequence revealed a high level (92%) of amino acid conservation for the 22K (M2) protein and identified a second, conserved ORF whose protein product remains to be identified. The high level of conservation of the 22K protein is of significance because it has been shown to be the major target antigen for RSV-specific cytotoxic T cells from infected mice (accompanying report).

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000498-04
Application #
3809679
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
McGivern, David R; Collins, Peter L; Fearns, Rachel (2005) Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity. J Virol 79:2449-60
Zhang, Liqun; Bukreyev, Alexander; Thompson, Catherine I et al. (2005) Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79:1113-24
Schomacker, Henrick; Collins, Peter L; Schmidt, Alexander C (2004) In silico identification of a putative new paramyxovirus related to the Henipavirus genus. Virology 330:178-85
Tran, Kim C; Collins, Peter L; Teng, Michael N (2004) Effects of altering the transcription termination signals of respiratory syncytial virus on viral gene expression and growth in vitro and in vivo. J Virol 78:692-9
Spann, Kirsten M; Collins, Peter L; Teng, Michael N (2003) Genetic recombination during coinfection of two mutants of human respiratory syncytial virus. J Virol 77:11201-11
Kotelkin, Alexander; Prikhod'ko, Elena A; Cohen, Jeffrey I et al. (2003) Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 77:9156-72
Zhang, Liqun; Peeples, Mark E; Boucher, Richard C et al. (2002) Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76:5654-66
Teng, Michael N; Collins, Peter L (2002) The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo. J Virol 76:6164-71
Techaarpornkul, Sunee; Collins, Peter L; Peeples, Mark E (2002) Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 294:296-304
Gower, T L; Peeples, M E; Collins, P L et al. (2001) RhoA is activated during respiratory syncytial virus infection. Virology 283:188-96

Showing the most recent 10 out of 19 publications